Abstract

Serotonin 5-HT2 receptors are expressed in many tissues and play important roles in biological processes. Although the 5-HT2A receptor is primarily known for its role in central nervous system, it is also expressed in peripheral tissues. We have found that 5-HT2A receptor antagonists inhibit human subcutaneous primary adipocyte differentiation. We also show that siRNA knockdown of the 5-HT2A receptor blocks differentiation. Using gene expression analysis in combination with receptor antagonists we found that activity of 5-HT2A receptors is necessary very early in the differentiation process to mediate expression of adipogenic genes, including peroxisome proliferator-activated receptor gamma (ppar-γ), adipocyte protein 2 (aP2), adiponectin, and serine/threonine-protein kinase 1 (sgk1). We show here for the first time that 5-HT2A receptor activity is necessary for differentiation of human primary subcutaneous preadipocytes to adipocytes, and that 5-HT2A receptor activity mediates key genes related to adipogenesis during this process. Importantly, this work contributes to a greater understanding of the adipocyte differentiation process, as well as to the role of 5-HT2A receptors in peripheral tissues, and may be relevant to the development of novel therapeutic strategies targeting this receptor for the treatment of obesity related diseases.

Highlights

  • Serotonin 5-HT2 receptors are expressed in many tissues and play important roles in biological processes

  • We have found no evidence for 5-HT2C receptor expression in human preadipocytes by qRT-polymerase chain reaction (PCR), and there is no report in the literature of human preadipocytes expressing 5-HT2C receptors

  • Following up on our earlier ­work[37], we present here conclusive evidence demonstrating that 5-HT2A receptor activity is necessary for differentiation in a more relevant adipose model system: primary human subcutaneous preadipocyte to adipocyte differentiation

Read more

Summary

Introduction

Serotonin 5-HT2 receptors are expressed in many tissues and play important roles in biological processes. Some research has implicated 5-HT2A receptor activity in metabolic processes, for example, activation of ­5HT2 receptors with the agonist DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane), has been reported to increase plasma glucagon levels in ­rats[23]. This hyperglucagonemia induced by DOI is dose-dependently prevented by the 5-HT2 receptor antagonist. A different antagonist at the 5-HT2A receptor, sapogrelate, has been reported to elevate adiponectin expression and to have insulin-sensitizing e­ ffects[25,26,27] Taken together, these studies support the notion that 5-HT2 receptors likely play an important, but as yet undefined, role in obesity-related diseases, including diabetes. Elucidation of the role of 5-HT2A receptors is likely to provide crucial information about these processes, and potentially to lead to new therapeutic avenues

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call